Chapter 1. Orphan Drugs Market- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Orphan Drugs Market- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Orphan Drugs Market- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Orphan Drugs Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4    .Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. Orphan Drugs Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Orphan Drugs Market- By Drug Type
6.1    Biological
6.2    Non-Biological
 
Chapter 7. Orphan Drugs Market- By Disease Type
7.1    Oncology
7.2    Hematology
7.3    Neurology
7.4    Cardiovascular
7.5    Others 
Chapter 8. Orphan Drugs Market- By Phase
8.1    Phase I
8.2    Phase II
8.3    Phase III
8.4    Phase IV
Chapter 9. Orphan Drugs Market- By Top Selling Drugs
9.1    Revlimid
9.2    Rituxan
9.3    Copaxone
9.4    Opdivo
9.5    Keytruda
9.6    Imbruvica
9.7    Avonex
9.8    Sensipar
9.9    Soliris
9.10    Others 
Chapter 10. Orphan Drugs Market- By Distribution Channel
10.1    Hospital Pharmacies
10.2    Retail Pharmacies
10.3    Online Stores
10.4    Others
Chapter 11. Orphan Drugs Market- By Region
11.1    North America
11.2    Europe
11.3    Asia-Pacific
11.4    Latin America
11.5    The Middle East
11.6    Africa
Chapter 12. Orphan Drugs Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1    Company 1
12.2    Company 2
12.3    Company 3
12.4    Company 4
12.5    Company 5
12.6    Company 6
12.7    Company 7
12.8    Company 8
12.9    Company 9
12.10    Company 10
 

Download Sample